baber/WOPTO huggingface dataset:
Patent DE-69625626-T2 (DE)
Inventor: RHOADS GEOFFREY B
IPC: G07F17/26
Filed: 1996-05-07
Granted: 2003-10-16
Abstract: A method of recognising content signals in a network of computing devices, the method comprising at a first network device in the network, obtaining a content signal distributed to the first network device transforming at least a portion of the content signal into a domain for recognition analysis processing the transformed signal to compute a pattern from the content signal determining an action authorised for the content signal by matching the pattern with a set of stored patterns with corresponding authorised actions and executing the authorised action at the first network.
Patent DE-69626218-T2 (DE)
Inventor: TUCKER A
IPC: C07D413/12
Filed: 1996-12-09
Granted: 2003-08-14
Abstract: This invention provides a novel oxazolidinone derivative represented by Formula I or pharmaceutical acceptable salts thereof:    <IMAGE>  I  wherein R1 is substituted or unsubstituted 2-pyrimidinyl, 4-pyrimidinyl, or 3-pyridazinyl; X is hydrogen or fluoro; R3 is C1-4 alkyl, C1-4 alkoxy, C3-6 cycloalkyl or C1-4 alkylamino or dialkylamino. The compounds are useful antimicrobial agents.
Patent DE-69628004-T2 (DE)
Inventor: COOK CHARLES
IPC: A61M39/06
Filed: 1996-05-22
Granted: 2004-02-26
Abstract: A patient fluid collection system is disclosed which includes a fluid collection reservoir, a cover for the reservoir, and a port on the reservoir having a scalloped upper edge. The scalloped upper edge prevents the port from being inadvertently closed off in the event that a tube valve containing a flapper valve is improperly positioned on the port.
Patent DE-69628871-T2 (DE)
Inventor: D ODORICO GIORGIO
IPC: A01K61/80
Filed: 1996-04-02
Granted: 2004-05-27
Abstract: The object of the invention is to provide a food conglomerate for fish in inert support, of the type having a convenient shape for aquariums, in which the food is contained in an inert substance as conglomerating support that encapsulates the same, to which the fish accedes by crumbling the inert substance, characterized in that said inert substance is on silica basis and contains at least the 50% of silica. <IMAGE>
Patent DE-69629430-T2 (DE)
Inventor: KAWAI TOMOYUKI
IPC: G11C29/04
Filed: 1996-09-26
Granted: 2004-06-09
Abstract: A semiconductor read-only memory includes a plurality of memory cell groups each having a plurality of memory cells, a first selector for selecting an arbitrary memory cell group from the plurality of memory cell groups, and a second selector for selecting an arbitrary memory cell from the selected memory cell group. The semiconductor read-only memory further includes: an address storage circuit for storing address information of a predetermined memory cell portion in a memory cell group; a data storage circuit for storing memory cell information of the predetermined memory cell portion; and a switching circuit for switching between information stored in the memory cell selected from the memory cell group and the memory cell information stored in the data storage circuit, based on the address information, and outputting either the information stored in the memory cell selected from the memory cell group or the memory cell information stored in the data storage circuit. <IMAGE>
Patent DE-69633159-T2 (DE)
Inventor: ECKHOUSE SHIMON
IPC: A61B18/00
Filed: 1996-09-11
Granted: 2005-09-08
Abstract: A method and apparatus for treating skin includes applying pulsed light to the skin to heat and shrinking collagen within the skin, thereby reviving the elasticity of the collagen and of the skin. The epidermis and outer layers of the skin may be protected by cooling with a transparent substance, such as ice or gel, to the skin. The temperature distribution within the skin is controlled by controlling the delay between the time the coolant is applied, and the time the light is applied, by controlling the pulse duration and applying multiple pulses, and by filtering the light and controlling the radiation spectrum, preferably, the spectrum includes the light having a wavelength in the range of 600-1200nm. The pulsed light may be incoherent, such as that produced by a flashlamp (301), or coherent, such as that produced by a Nd(Yag) laser or a ruby laser, and may be directed to the skin using a flexible or rigid light guide (305). Also, a method and apparatus for cutaneous resurfacing including directing Er:YAG laser light to the skin. The light may be pulsed, preferably with a delay of about 0.5-10msec between pulses. In one embodiment the pulses have energy fluences of preferably about 100J/cm<2>.
Patent DE-69705169-T2 (DE)
Inventor: CARMONA NATHALIE
IPC: C07B61/00
Filed: 1997-07-02
Granted: 2002-03-07
Abstract: Preparation of 2-oxo cyclohexylidene acetic acid enol-lactone (I) comprises: (i) reacting glyoxylic acid with cyclohexanone in the presence of a halogenated acid to give a crude reaction product; and (ii) dissolving the above product in an organic solvent in the presence of a strong soluble acid or a strongly acidic resin. In (i), the acid is preferably HCl added in a 1-100% molar amount w.r.t. glyoxylic acid and the reagents are heated above 50 degrees C. The resulting crude product is dissolved in a solvent containing a benzene ring and treated with methane sulphonic acid or p-toluene sulphonic acid or with a strongly acidic sulphonic Amberlist (RTM) resin.
Patent DE-69714989-T2 (DE)
Inventor: BOWEN LARRY
IPC: A24F13/00
Filed: 1997-05-02
Granted: 2003-04-30
Abstract: PCT No. PCT/CA97/00297 Sec. 371 Date Sep. 26, 1999 Sec. 102(e) Date Sep. 26, 1999 PCT Filed May 2, 1997 PCT Pub. No. WO97/41744 PCT Pub. Date Nov. 13, 1997A cigarette combustion unit for the use in a hand-held cigarette smoke filtering device for filtering sidestream smoke emitted from a cigarette burning in the unit comprising: i) an elongate closed combustion chamber for a burning cigarette, a lower wall portion of the combustion chamber at least having an air porous portion to permit air to enter the combustion chamber, ii) a cigarette holder in an end of the combustion chamber for holding a cigarette in the combustion chamber with its burning end spaced from chamber interior wall surfaces, and iii) a sidestream smoke outlet in the end above the cigarette holder.
Patent DE-69717293-T2 (DE)
Inventor: HO BERT
IPC: A61K47/12
Filed: 1997-09-17
Granted: 2003-09-04
Abstract: The present invention relates to novel formulations of corticotropin releasing factor (CRF) having improved stability during storage over extended periods of time as liquids, which retain significant pharmaceutical activity during such storage and/or which are physiologically compatible. The formulations of the present invention comprise (a) a pharmaceutically effective concentration of CRF, (b) a buffer to maintain the pH of the formulation between about 2.0 to about 5.0 or about 6.0 to about 9.0 when in liquid form and (c) an alcohol such as mannitol, sorbitol, methanol, glycerol, or the like. Other aspects of the present invention involve addition of various other components to the formulations described herein for the purpose of decreasing the rate of degradation of the CRF peptide or increasing its solubility in solution. Finally, the present invention is further directed to methods for preparing such novel pharmaceutical formulations of CRF and methods of using those formulations to reduce inflammation and edema in mammals.
Patent DE-69722440-T2 (DE)
Inventor: SEPPAELAE JUKKA
IPC: A61K6/891
Filed: 1997-12-16
Granted: 2004-05-06
Abstract: A plasticizable implant material for injection into the human body. The implant material is prepared through simultaneous selection of the comonomer ratio of epsi-caprolactone and lactide and production parameters to provide a (co)polymer having an average molecular weight and caprolactone concentration that produces a phase transition temperature from solid to fluid within a temperature range of 37-55° C., preferably within the range of 43-48° C. When the temperature of the implant material is regulated to be within said range it can easily be transported to and placed at its target in the body by using a fluid transport and dosing device like a syringe or a heated press.
Patent DE-69724960-T2 (DE)
Inventor: BLAZEJEWSKI G
IPC: B01D53/44
Filed: 1997-05-20
Granted: 2004-07-15
Abstract: Regenerative thermal oxidizer in which a gas such as contaminated air is first passed through a hot heat-exchange bed and into a communicating high temperature oxidation (combustion) chamber, and then through a relatively cool second heat exchange bed. The apparatus includes a number of internally insulated, ceramic filled heat recovery columns topped by an internally insulated combustion chamber. Process air is fed into the oxidizer through an inlet manifold containing a number of hydraulically or pneumatically operated flow control valves (such as poppet valves). The air is then directed into the heat exchange media which contains "stored" heat from the previous recovery cycle. The process air is heated to near oxidation temperatures. Oxidation is completed as the flow passes through the combustion chamber, where one or more burners are located. The gas is maintained at the operating temperature for an amount of time sufficient for completing destruction of the VOC's. From the combustion chamber, the gas flows vertically downward through another column containing heat exchange media, thereby storing heat in the media for use in a subsequent inlet cycle when the flow control valves reverse. The resulting clean air is directed via an outlet valve through an outlet manifold and released to atmosphere at a slightly higher temperature than inlet, or is recirculated back to the oxidizer inlet. An integrated VOC entrapment chamber entraps any VOC's that leak out during cycling, and recycles them back to the oxidizer inlet for further processing.
Patent DE-69737980-T2 (DE)
Inventor: GARVEY DAVID S
IPC: C07C217/60
Filed: 1997-01-28
Granted: 2007-12-06
Abstract: Disclosed are nitrosated and nitrosylated  alpha -adrenergic receptor antagonists, compositions of an  alpha -adrenergic receptor antagonist ( alpha -antagonist), which can optionally be substituted with at least one NO or NO2 moiety, and a compound that donates, transfers or releases nitric oxide as a charged species, i.e., nitrosonium (NO+) or nitroxyl (NO-), or as the neutral species, nitric oxide (NO+574 ); and uses for each of them in treating human male impotence or erectile dysfunction.
Patent DE-69800444-T2 (DE)
Inventor: MORK JOHN
IPC: B62D55/26
Filed: 1998-02-10
Granted: 2001-04-19
Abstract: The invention relates to a vehicle track for tracked off-road vehicles intended for use in all types of terrain, both hilly terrain and in wetlands and on different types of ground surfaces, such as asphalt, concrete, gravel, sand, stone, snow and ice. The track (10) includes one or more endless traction elements (12) made of an elastomeric material, and cross-ribs (11) which are spaced apart generally equidistantly and extend transversely and outwardly from the traction element (12). The cross-ribs are intended for contact with the ground when moving the vehicle, wherewith at least those parts of the cross-ribs (11) which come into contact with the ground are comprised of a polymeric material (27) which is firmly held and supported by a flexurally rigid support device (26). The vehicle track is characterized in that the support device (26) is comprised of a fully closed profile construction, and in that the polymeric material (27) is applied to the outside of said profile construction. The profile construction (26) is conveniently produced from a material chosen from the group: high-quality steel, aluminium, magnesium or composite material, although preferably from a boron-alloyed, high-strength steel. The polymeric material (27) in the cross-ribs (11) is suitably pressed-moulded around the fully closed profile construction (26). <IMAGE>
Patent DE-69800493-T2 (DE)
Inventor: CHEHADI MOHAMAD
IPC: G11C29/50
Filed: 1998-10-14
Granted: 2001-05-03
Abstract: As the high voltage and low voltage command are applied separately, all access modes can be used at the same time, thus gaining time.
Patent DE-69801400-T2 (DE)
Inventor: LAVIELLE GILBERT
IPC: C07D491/052
Filed: 1998-06-23
Granted: 2002-05-16
Abstract: Hexahydro-chromeno-Ä3,4-cÜ-pyrrole derivatives of formula (I), their enantiomers, diastereoisomers and salts are new. m = 0-3; n = 0-3; n+m = 2 or 3; p = 1-6; the junction between rings B and C is trans; X = CN or -CONR4R5; R4, R5 = H, 1-6C alkyl, 3-7C cycloalkyl or optionally substituted aryl; A = sigma bond or -NR-CO-, -CO-NR-, -NR-SO2-, or -SO2-NR-; R = H or 1-6C alkyl; R1, R2 = H or 1-6C alkyl; R3 = H or phenyl, naphthyl or heteroaryl (all optionally substituted by one or more halo, 1-6C alkyl or alkoxy, OH, CN, NH2, NO2, COOH, 1-6C perhaloalkyl, sulphonyl, acylamino, 1-6C alkylsulphonyl, or 1-6C alkyl sulphonylamino), aryl or heteroaryl (both substituted by A'-Cy), 2-indolinon-5-yl, or, when A is a sigma bond, aryloxy or arylthio; A' = sigma bond or 1-6C alkylene or alkenylene, (in which one C atom may be replaced by O or S), -NR-CO-, -CO-NR-, -NR-SO2-, or -SO2-NR-; Cy = aryl or heteroaryl (optionally substituted); provided that when n = 0, then m is other than 2, when n = 1, R1, R2 = H, A = sigma bond and p = 1, then R3 is not phenyl nor pyridyl, when n = 1, R1 & R2 = H, A = sigma bond, R3 is not H, when n = 1, R1 & R2 = H, A = -NH-CO-, then R3 is other than H, phenyl, naphthyl, thienyl, furyl, pyrrolyl, pyridyl, (all optionally substituted by one or more halo, trihalomethyl, alkoxy or OH).
Patent DE-69816493-T2 (DE)
Inventor: OHNO KOUSAKU
IPC: A61K35/12
Filed: 1998-01-08
Granted: 2004-04-15
Abstract: An object of the present invention is to offer a pharmaceutical composition containing an extract from inflammatory tissue inoculated with vaccinia virus having a suppressing action to death of cells and an excessive production of nitrogen monoxide induced by endotoxin and an improving action to hypotension induced by endotoxin. The present invention is a novel pharmaceutical composition containing an extract from inflammatory tissue inoculated with vaccinia virus such as a nitrogen monoxide production suppressor, a therapeutic agent for sepsis, an antiendotoxinic agent and a therapeutic agent for endotoxin shock. In sepsis and other serious bacterial infectious diseases, endotoxin (an intracellular toxin) is produced and a shock symptom is induced by its action. Accordingly, the substance of the present invention having an excellent inhibitory action to the endotoxin-induced toxicity as mentioned above is quite useful for the treatment or the prevention of endotoxin-induced shock symptom, sepsis and various symptoms accompanied thereby. In addition, the substance of the present invention has an inhibitory action to abnormal nitrogen monoxide production during the diseased state and, therefore, it is also useful as a therapeutic and preventive agent to the diseases wherein an excessive nitrogen monoxide production is participated such as acute hypotension.
Patent DE-69827503-T2 (DE)
Inventor: ISSERSTEDT ROBERT K
IPC: B42F17/18
Filed: 1998-02-13
Granted: 2005-10-20
Abstract: A storage service comprises a support structure (1) carrying a plurality of receptacle (11) such as document pouches arranged in a longitudinal series. The support structure has a pair of spaced side members (4, 5) which are foldable so that the pouches may be arranged either in a closed up array or suspended in an openend out array. Support members (6) extend laterally between the side members (4, 5) and the pouches (11) are releasably supported on the support members and extend through gaps (3) between the support members. The pouches have closure flaps (15) which can be folded backwards over the support members (6) to suspend the pouches from them. A locating tab (10) may pass through an aperture (16) in the pouch and be folded over to hold the pouch to the support member (6). The support structure is made from a sheet of material provided with apertures (3) which define the side and support members (4, 5, 6).
Patent DE-69837885-T2 (DE)
Inventor: RUEGER DAVID C
IPC: A61K38/18
Filed: 1998-09-09
Granted: 2008-02-07
Abstract: A synergistic effect of OP/BMP morphogens in combination with GDNF/NGF neurotrophic factors in promoting the survival or growth, or inhibiting the death or degeneration, of mammalian cells, particularly neural cells, which express OP/BMP-activated serine/threonine kinase receptors and GDNF/NGF-activated tyrosine kinase receptors, is disclosed. Also disclosed are new methods for the in vivo and in vitro treatment of such cells, including in vivo treatments for mammals afflicted with, or at imminent risk of, damage or injury to such cells, as well as new pharmaceutical preparations for such in vivo and in vitro treatments.
Patent DE-69838552-T2 (DE)
Inventor: COX GEORGE N
IPC: C07K14/505
Filed: 1998-07-13
Granted: 2008-05-21
Abstract: The growth hormone supergene family comprises greater than 20 structurally related cytokines and growth factors. A general method is provided for creating site-specific biologically active conjugates of these proteins. The method involves adding cysteine residues to non-essential regions of the proteins or substituting cysteine residues for non-essential amino acids in the proteins using site-directed mutagenesis and then covalently coupling a cysteine-reactive polymer or other type of cysteine-reactive moiety to the proteins via the added cysteine residue. Disclosed herein are preferred sites for adding cysteine residues or introducing cysteine substitutions into the proteins, and the proteins and protein derivatives produced thereby.
Patent DE-69903047-T2 (DE)
Inventor: BENTZON DELEURAN
IPC: G01R33/12
Filed: 1999-07-15
Granted: 2003-10-23
Abstract: The invention relates to a method for the determination of the critical current for a conductor including superconducting material. The conductor is brought into a superconducting state, and a varying external magnetic field is generated through which said conductor is conveyed. A first measurement means is used to carry out a first contact-free measurement of the resulting magnetic field that occurs as a consequence of the influence of said external magnetic field on the conductor. The part of the resulting magnetic field out of phase with the external magnetic field is determined, and the critical current of the conductor is determined on the basis thereof. The invention further relates to an apparatus for performing the method.
Patent DE-69903323-T2 (DE)
Inventor: BUNKER JAMES
IPC: F16D65/12
Filed: 1999-07-26
Granted: 2003-05-22
Abstract: A disc brake (10) comprising at least two discs (12, 14), and a hub (16) which is arranged to rotate about an axis (18) thereof. The system (10) also comprises mounting arrangement (20,22) by which the discs (12, 14) are mounted on the hub (16) so that the hub and the discs rotate as a unit about the axis (18) and the discs can perform axial sliding movement on the hub. The system (10) also comprises a plurality of leaf springs (42) mounted on the hub (16) and engaging the discs (12, 14) so that the springs apply force between the discs and the hub. The leaf springs (42) are arranged in groups, one spring in each group acting on each disc, at least one spring in each group being retained in position by a connection (44) to another spring in the group.
Patent DE-69910829-T2 (DE)
Inventor: TJEENK WILLINK ANTONIE
IPC: B01D53/00
Filed: 1999-12-29
Granted: 2004-02-26
Abstract: A nozzle of converging-diverging shape for creating mist flow at supersonic velocity comprising: a throat having a characteristic diameter D*; an inlet having a characteristic diameter D1, positioned a distance L1 upstream of the nozzle throat; and an outlet having a characteristic diameter D2, positioned a distance L2 downstream of the nozzle throat, wherein the ratio of L2/(D2-D*) is larger than 4, but smaller than 250; an inertia separator based thereon, and a method for supersonic separation of one or more components of a predominantly gaseous stream.
Patent DE-69913279-T2 (DE)
Inventor: ANDERSEN ERIK HAARBO
IPC: E05D1/04
Filed: 1999-09-16
Granted: 2004-09-16
Abstract: The invention concerns a hinge (1) for a hinge connection between door/gate sections comprising a first (2) and a second (3) hinge profile, said hinge profiles (2,3) comprising a link function (4) lying between the two profiles for the provision of an axis of rotation (5) and hinging around which the two profiles turn, said first hinge profile (2) comprising an outer profile (6), and said second hinge profile (3) comprising an inner profile (7) lying at a shorter distance to the link connection (4) than the outer profile (6) and with its outer surface (8) facing towards the outer profile (6), the inner surface (12) of said outer profile is substantially plane, and the outer surface (8) of said inner profile comprising a curved part (9) extending from the free concluding edge (10) of the profile and at a distance hereto. The curved part (9) is concentric with the axis of rotation (5), and the remaining outer surface (11) is substantially plane and forms an angle of 0 - ¦15 DEG ¦ with the inner surface (12) of the outer profile, the inner surface of said outer profile being mainly plane parallel with the gate sections when the hinge (1) is in the closed position, said outer profile (6) substantially covering the inner profile (7) when the hinge (1) is in the closed position, and in that each hinge profile (2,3) respectively comprises a first (18) and a second (19) area for the mounting of securing elements (20) which connect each hinge profile to a section (26)/a frame (33). There is hereby achieved a narrow profile hinge which, however, has room for mounting screws, and which at the same time provides optimum protection for the fingers. <IMAGE>
Patent DE-69913489-T2 (DE)
Inventor: KOLEDIN MICHAEL JANIS
IPC: A61F5/055
Filed: 1999-01-14
Granted: 2004-09-16
Abstract: An emergency extrication collar comprising a flexible band for encircling the wearer's neck, a chin support member which may be readily adjusted in elevation with respect to the band so as to permit adjustment to fit patients having varying neck sizes. The chin support member is connected to the band by a post which is slidably connected to a vertical strap on the band, and such that the elevation of the chin support member above the post, and thus the neck size of the collar, may be adjusted by simply sliding the post and chin support upwardly to any selected size between the size extremes. A pawl and ratchet interconnection between the post and strap precludes movement in the opposite direction. The collar is secured in its adjusted size by a locking arm which is pivotally mounted on the post, and movement of the locking arm to its release position also releases the pawl and ratchet interconnection.
Patent DE-69922478-T2 (DE)
Inventor: NEWTON MICHAEL DAVID
IPC: B60S5/04
Filed: 1999-07-23
Granted: 2005-12-15
Abstract: A pneumatic system consists of an inflatable/deflatable article, for example, a compression garment ( 21 ) connected to a pump ( 20 ) by connectors (12 and 11), respectively. The connector ( 12 ) attached to the garment ( 21 ) carries an RFID transponder ( 30 ) and a corresponding radio circuit ( 31 ) is located within the pump ( 20 ). In use, the transponder ( 30 ) transmits and receives information to and from the pump radio circuit ( 31 ). The information exchanged is used by the pump control system to activate the pump and to operate the pump to provide the particular operating parameters for that garment, for example, pressure, inflation/deflation cycle, duration of treatment, etc.
Patent DE-69925992-T2 (DE)
Inventor: HONMA TSUNETOSHI
IPC: C07D333/64
Filed: 1999-03-30
Granted: 2006-05-24
Abstract: Benzothiophenecarboxylic acid derivatives of the formula (I) which are useful as starting materials for producing drugs, and a process for preparing 5-hydroxybenzo[b]thiophene-3-carboxylic acid derivatives of the formula (VI) which are specific PGD<sub>2</sub> antagonists.